E-LIB Suche - Ergebnisse für: Brannan, Stephen

1

The Impact of Baseline Anxiety on Drug Placebo Separation a..:

Kott, Alan ; Brannan, Stephen ; Wang, Xingmei.
Schizophrenia Bulletin Open. 4 (2023) 1 - p. , 2023

Link: https://doi.org/10.1093/..

2

The Impact of Aberrant Data Variability on Drug–Placebo Sep..:

Kott, Alan ; Brannan, Stephen ; Wang, Xingmei.
Schizophrenia Bulletin Open. 2 (2021) 1 - p. , 2021

Link: https://doi.org/10.1093/..

3

Efficacy and Safety of Xanomeline, a M1/M4 Receptor Prefere..:

Brannan, Stephen ; Sawchak, Sharon ; Miller, Andrew..
Biological Psychiatry. 87 (2020) 9 - p. S169 , 2020

Link: https://doi.org/10.1016/..

4

Hemorrhagic Fevers:

, In: Highly Infectious Diseases in Critical Care,

Sullivan, James ; Brannan, Stephen - p. 119-138 , 2020

Link: https://doi.org/10.1007/..

5

32.2 TWO GLOBAL PHASE III TRIALS OF ENCENICLINE FOR COGNITI..:

Brannan, Stephen
Schizophrenia Bulletin. 45 (2019) Supplement_2 - p. S141-S142 , 2019

Link: https://doi.org/10.1093/..

6

T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE ..:

Brannan, Stephen ; Miller, Andrew ; Felder, Christian..
Schizophrenia Bulletin. 45 (2019) Supplement_2 - p. S244-S245 , 2019

Link: https://doi.org/10.1093/..

7

P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELA..:

Budur, Kumar ; Welsh‐Bohmer, Kathleen ; Burns, Daniel...
Alzheimer's & Dementia. 10 (2014) 4S_Part_22 - p. , 2014

Link: https://doi.org/10.1016/..

8

O4‐07‐01: EFFECTS OF PIOGLITAZONE ON MNEMONIC HIPPOCAMPAL F..:

Brannan, Stephen ; Hariri, Ahmad ; Knodt, Annchen...
Alzheimer's & Dementia. 10 (2014) 4S_Part_4 - p. , 2014

Link: https://doi.org/10.1016/..

9

Assessing cognition and function in Alzheimer's disease cli..:

Snyder, Peter J. ; Kahle‐Wrobleski, Kristin ; Brannan, Stephen...
Alzheimer's & Dementia. 10 (2014) 6 - p. 853-860 , 2014

Link: https://doi.org/10.1016/..

10

O1–06–01: Challenges in international clinical trials to de..:

Welsh‐Bohmer, Kathleen ; Romero, Heather ; Hayden, Kathleen...
Alzheimer's & Dementia. 9 (2013) 4S_Part_3 - p. , 2013

Link: https://doi.org/10.1016/..

11

P4–065: A pharmacogenetics‐supported clinical trial to dela..:

Roses, Allen ; Welsh‐Bohmer, Kathleen ; Burns, Daniel...
Alzheimer's & Dementia. 9 (2013) 4S_Part_18 - p. , 2013

Link: https://doi.org/10.1016/..

12

P1–367: Delaying early phases of cognitive decline associat..:

Brannan, Stephen ; Burns, Daniel ; Malholtra, Manoj...
Alzheimer's & Dementia. 9 (2013) 4S_Part_7 - p. , 2013

Link: https://doi.org/10.1016/..

13

P4‐269: A pharmacogenetic‐supported clinical trial to delay..:

Roses, Allen D. ; Welsh‐Bohmer, Kathleen ; Burns, Daniel...
Alzheimer's & Dementia. 8 (2012) 4S_Part_20 - p. , 2012

Link: https://doi.org/10.1016/..

14

Switching from Donepezil Tablets to Rivastigmine Transderma..:

Sadowsky, Carl H. ; Dengiz, Alan ; Olin, Jason T....
American Journal of Alzheimer's Disease & Other Dementiasr. 24 (2009) 3 - p. 267-275 , 2009

Link: https://doi.org/10.1177/..

15

Safety and tolerability of rivastigmine capsule with memant..:

Olin, Jason T. ; Bhatnagar, Vinod ; Reyes, Patricio...
International Journal of Geriatric Psychiatry. 25 (2009) 4 - p. 419-426 , 2009

Link: https://doi.org/10.1002/..